This is a meta‐analysis of randomized controlled trials (RCTs) investigating the effects of
oral vitamin D supplementation on serum fibroblast growth factor‐23 (FGF23) concentrations …

The phosphaturic hormone fibroblast growth factor 23 (FGF23) is a risk marker of
cardiovascular and all-cause mortality. We therefore aimed to synthesize the evidence for …

Background The purpose of the present study was to determine the effect of additional
calcium carbonate treatment on fibroblast growth factor 23 (FGF23) levels in patients treated …

Fibroblast growth factor (FGF) 23 is an important regulator of phosphaturia. Its serum level
was found to increase before that of parathyroid hormone (PTH) in early chronic kidney …

Background: Fibroblast growth factor-23 (FGF23) is a phosphaturic factor that is released
from bone. A variety of bone diseases can occur in renal diseases. Objectives: This study …

Recently, a new view of the molecular mechanisms of phosphate homeostasis and
secondary hyperparathyroidism pathogenesis has been proposed, with fibroblast growth …

Introduction The heightened fibroblast growth factor 23 (FGF23) level in patients with chronic
kidney disease (CKD) is associated with increased cardiovascular disease and mortality …

The discovery of fibroblast growth factor 23 (FGF23) has clarified much of our understanding
of abnormalities in phosphorus and vitamin D metabolism in chronic kidney disease (CKD) …

Background Elevated fibroblast growth factor-23 (FGF23) levels increase the risk of
cardiovascular diseases in patients with chronic kidney disease (CKD). We aimed to …

Background: Serum intact fibroblast growth factor 23 (FGF23) levels are progressively
increased in relation to the severity of kidney dysfunction. High serum intact FGF23 …